LipiFlow Treatment for Meibomian Gland Dysfunction Approved by FDA

July 12, 2011

Submit Comments
Dr. Ari Weitzner

TearScience, Inc., announced yesterday that the FDA had cleared its LipiFlow® Thermal Pulsation System for the treatment of meibomian gland dysfunction (MGD), one of the leading causes of dry eye. The clearance enables TearScience to market and sell LipiFlow® to eye care physicians in the U.S. LipiFlow® will be available immediately, but on a limited basis in the U.S. through the end of 2011. LipiFlow® removes meibomian gland obstructions by applying directed energy to a patient’s eyelid during a 12-minute in-office treatment.

Click here to learn more.

 

 

Print this post
 

Bookmark

 
Filed in Dry Eye, Industry News, New Technologies Tagged , ,


Comments

Jump down to form below to submit your own comments

4 Responses to “LipiFlow Treatment for Meibomian Gland Dysfunction Approved by FDA”

  • Laurie
    on September 23, 2014 11:40 pm

    I’m looking for a Dr. In cleveland area using lipaflow ?

  • john magari
    on August 10, 2012 8:45 am

    Where can I find a doctor in MIchigan that does LipiFlow? I would appreciate the feedback. Otherwise I have to call all around searching for a doctor who does this procedure. Thank You John Magari

  • ari
    on September 26, 2011 11:25 pm

    i dont know- sorry

  • Harold Pechakjian
    on September 26, 2011 10:04 pm

    Are there any Doctors in the southern california area who are performing Lipiflow?

    Thanks.